Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (141-150 of 917) with videos related to

Pageof 92
Sort By:
European Urology|April 5, 2011
Full functional-length urethral sphincter preservation during radical prostatectomyThorsten Schlomm, Hans Heinzer, Thomas Steuber, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2016
Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?Christian Gerlich, Michael Schuler, Matthias Jelitte, et al.
Urologic Oncology|March 13, 2019
Impact of the estimated blood loss during radical prostatectomy on functional outcomesFelix Preisser, Raisa S Pompe, Georg Salomon, et al.
European Urology Focus|January 5, 2019
The Impact of Anxiety and Depression on Surgical and Functional Outcomes in Patients Who Underwent Radical ProstatectomyRaisa S Pompe, Alexander Krüger, Felix Preisser, et al.
Anticancer Research|December 11, 2013
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancerRudolf Moritz, Jörg Ellinger, Philipp Nuhn, et al.
Prostate International|October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancerFelix Preisser, Felix K-H Chun, Severine Banek, et al.
European Urology Focus|February 4, 2025
Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical ProstatectomyReha-Baris Incesu, Felix Preisser, Raisa S Pompe, et al.
European Urology|June 9, 2009
Current technique of open intrafascial nerve-sparing retropubic prostatectomyLars Budäus, Hendrik Isbarn, Thorsten Schlomm, et al.
The Journal of Urology|November 25, 2003
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsiesAlexander Haese, Markus Graefen, Thomas Steuber, et al.
BJU International|March 24, 2007
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancerFelix K-H Chun, Pierre I Karakiewicz, Alberto Briganti, et al.
Pageof 92

Showing results (141-150 of 917) with videos related to

Sort By:
Pageof 92
European Urology|April 5, 2011
Full functional-length urethral sphincter preservation during radical prostatectomyThorsten Schlomm, Hans Heinzer, Thomas Steuber, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2016
Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?Christian Gerlich, Michael Schuler, Matthias Jelitte, et al.
Urologic Oncology|March 13, 2019
Impact of the estimated blood loss during radical prostatectomy on functional outcomesFelix Preisser, Raisa S Pompe, Georg Salomon, et al.
European Urology Focus|January 5, 2019
The Impact of Anxiety and Depression on Surgical and Functional Outcomes in Patients Who Underwent Radical ProstatectomyRaisa S Pompe, Alexander Krüger, Felix Preisser, et al.
Anticancer Research|December 11, 2013
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancerRudolf Moritz, Jörg Ellinger, Philipp Nuhn, et al.
Prostate International|October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancerFelix Preisser, Felix K-H Chun, Severine Banek, et al.
European Urology Focus|February 4, 2025
Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical ProstatectomyReha-Baris Incesu, Felix Preisser, Raisa S Pompe, et al.
European Urology|June 9, 2009
Current technique of open intrafascial nerve-sparing retropubic prostatectomyLars Budäus, Hendrik Isbarn, Thorsten Schlomm, et al.
The Journal of Urology|November 25, 2003
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsiesAlexander Haese, Markus Graefen, Thomas Steuber, et al.
BJU International|March 24, 2007
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancerFelix K-H Chun, Pierre I Karakiewicz, Alberto Briganti, et al.
Pageof 92